GABAPENTIN 100 MG CAPSULES
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
01-04-2023
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
GABAPENTIN
Available from:
Lexon (UK) Ltd
Dosage:
100 Milligram
Pharmaceutical form:
Capsule
Authorization date:
2005-06-10
Summary of Product characteristics
License
IRISH MEDICINES BOARD ACT 1995
MEDICINAL PRODUCTS(LICENSING AND SALE)REGULATIONS, 1998
(S.I. No.142 of 1998)
PA1097/001/001
Case No: 2027938
The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to
Lexon (UK) Ltd
Unit 18, Oxleasow Road, East Moons Moat, Worcestershire B98 0RE, United Kingdom
an authorisation, subject to the provisions of the said Regulations, in respect of the product
Gabapentin 100 mg Capsules
The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as
may be specified in the said Regulations as listed on the reverse of this document.
This authorisation, unless previously revoked, shall continue in force from 31/10/2006 until 09/06/2010.
Signed on behalf of the Irish Medicines Board this
________________
A person authorised in that behalf by the said Board.
Irish Medicines Board
______________________________________________________________________________________________________________________
Date Printed 01/11/2006
CRN 2027938
page number: 1
Part II
Summary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT
Gabapentin 100 mg Hard Capsules
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 100 mg
Read the complete document
